Sep 28

Scientific

SS 21 - Immuno-Radiotherapy and Liquid Biomarkers in Gynecologic Cancer: Toward Precision Care

03:00pm - 04:00pm ET

Gynecological Cancer

MODERATOR(S)

Eric Leung, MD - Sunnybrook Health Sciences Centre

Cristina DeCesaris, MD - University of Utah Huntsman Cancer Institute

Credits

AMA PRA Category 1 Credits:

1.00

Rate This Session

Presentations

03:00pm - 03:10pm ET

Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study

Speaker: Kamran Ahmed, MD - H. Lee Moffitt Cancer Center, Tampa
03:10pm - 03:20pm ET

The Prognostic Role of Circulating Tumor DNA In Vulvovaginal Cancers Undergoing Radiotherapy

Speaker: Bin Gui, MD, MS - Northwell Health, Lake Success
03:20pm - 03:30pm ET

Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives

Speaker: Yuan Jie Cao, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tian Jin
03:30pm - 03:40pm ET

Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report

Speaker: Bin Gui, MD, MS - Northwell Health, Lake Success
03:40pm - 03:50pm ET

Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) Targeting the Cervical Primary in Stage IVB Cervical Cancer: Results of a Phase I Trial

Speaker: Kevin Albuquerque, MD - Simmons Comprehensive Cancer Center, UTSW Radiation Oncology, Dallas
03:50pm - 04:00pm ET

Discussant

Speaker: Jyoti Mayadev, MD, FASTRO - UCSD, La JOlla
03:50pm - 04:00pm ET

Discussant

Speaker: Jyoti Mayadev, MD, FASTRO - UCSD, La JOlla